Clinical Research Directory
Browse clinical research sites, groups, and studies.
Healthy Adult Participants Trial Comparing Different Cenvacibart Presentations
Sponsor: Regeneron Pharmaceuticals
Summary
This trial is being done in non-obese healthy participants to compare two different forms of cenvacibart. The main goal of the trial is to learn about the trial medicine and how it is absorbed, modified, and removed from the body. The trial will look at: * What side effects cenvacibart might cause and how it feels after the dose * Levels of cenvacibart in the blood at different time points * Whether the body makes proteins called antibodies against cenvacibart (which could make the trial medicine less effective or could lead to side effects) * What happens when cenvacibart travels through the body
Official title: A Phase 1, Randomized, Open-Label, Single-Dose Trial to Compare the Pharmacokinetics, Safety, and Tolerability of Different Cenvacibart (REGN7508) Presentations in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-11-23
Completion Date
2027-05-14
Last Updated
2026-10-15
Healthy Volunteers
Yes
Conditions
Interventions
Cenvacibart
Administered per the protocol